As of Feb 27
| -0.105 / -1.83%|
The 3 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 15.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +165.72% increase from the last price of 5.65.
The current consensus among 3 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.